Nanologica Engages Scientific Advisors within Inhalation
Nanologica AB has engaged two senior scientific advisors within the field of respiratory drug delivery, for the purpose of advancing the NLAB Spiro™ inhalation platform further.Dr. John Pritchard has more than 40 years of experience from the inhalation industry working in various positions, leading and managing global portfolios of technology projects from discovery to market, at for example GlaxoSmithKline, 3M Health Care Ltd and as Head of Respiratory Project Management at AstraZeneca. His vast experience from the respiratory drug delivery field also includes serving on a Technical